Form 4: Insmed CEO William Lewis Sells Shares for Tax Obligations

Insmed Chair and CEO William Lewis sold 7,605 shares of common stock to satisfy tax withholding obligations related to RSU vesting.

Summary

• William Lewis, Chair and CEO of Insmed Inc (INSM), sold 7,605 shares of common stock on June 3, 2026.
• The shares were sold at a price of $102.27 per share.
• The transaction was executed to satisfy tax withholding obligations resulting from the vesting of Restricted Stock Units (RSUs).
• Following the transaction, William Lewis maintains direct ownership of 265,432 shares and indirect ownership of 233,924 shares held by a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was purely for tax compliance and does not reflect a change in the CEO's outlook on the company.

Positives

• The sale was non-discretionary, specifically conducted to cover tax liabilities associated with equity compensation vesting.

Negatives

• Reduction in direct equity stake held by the CEO.

Risks

• None identified; this is a routine administrative transaction related to tax compliance.

Future Outlook

Not applicable as this is a retrospective disclosure of an insider transaction.

Industry Context

StockSavvy.ai notes that routine insider selling for tax withholding purposes is a standard corporate practice and does not typically signal a change in management sentiment regarding the company's long-term prospects.

Comparison to Industry Standards

• The transaction aligns with standard executive compensation practices where equity awards are settled net of tax.

Stakeholder Impact

• Minimal impact on shareholders as the sale was for tax obligations rather than a discretionary divestment.

Key Dates

Keywords

Insmed, INSM, Insider Trading, Form 4, William Lewis, Equity Compensation